Receptor tyrosine kinase inhibition by regorafenib/sorafenib inhibits growth and invasion of meningioma cells - Concepedia

Concepedia

Publication | Closed Access

Receptor tyrosine kinase inhibition by regorafenib/sorafenib inhibits growth and invasion of meningioma cells

38

Citations

42

References

2017

Year

Marcus Tuchen, Annette Wilisch-Neumann, Evelyn A. Daniel, Lisa Baldauf, Doreen Pachow, Johannes Scholz, Frank Angenstein, Oliver Stork, Elmar Kirches, Christian Mawrin

European Journal of Cancer

Signaling PathwayMedicineReceptor Tyrosine KinaseCancer GrowthMeningioma CellsAnti-cancer AgentRegorafenib/sorafenib Inhibits GrowthPharmacologyCell BiologyCell SignalingDrug Discovery

References

	Year	Citations

Page 1

Page 1